+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Status Unknown

Phase Not Applicable
Age: 25Years - 65Years
All Genders
Healthy Volunteers
ID06463938

A Clinical Study to Evaluate the Effectiveness of Casein Phosphopeptide, Amorphous Calcium Phosphate Paste CPP-ACP Used Alone or in Combination With Lasotronix Diode Laser to Treat Dentin Hypersensitivity

Led by Dow University of Health Sciences · Updated on 2024-07-26

120

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What this Trial Is About

Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).

CONDITIONS

Brief Title

A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH

Research Team

S

Sanam Dr Faheem, MSc

C

Chandar Dr Kumar

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here